Tipe3 is a candidate prognostic biomarker promoting tumor progression via elevating rac1 in pancreatic cancer

HIGHLIGHTS

• who: Zequn Li from the A prospective cohort was established from Jan , to Dec, which composed of , patientsThe data was gained until Dec, . Written informed consent was obtained from each patient, and this study was approved by the Ethics Committee of Shandong University and the Ethics Committee of Qingdao University, China. (Approval number, KYLL- KS-114). Immunohistochemistry (IHC) and evaluation have published the article: TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer, in the Journal: (JOURNAL)
• what: The authors sought to explore whether TIPE3 is a biomarker for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.